RTW Venture Fund Limited Quarterly Update (9316D)
2022年10月25日 - 03:00PM
RNSを含む英国規制内ニュース (英語)
TIDMRTW
RNS Number : 9316D
RTW Venture Fund Limited
25 October 2022
LEI: 549300Q7EXQQH6KF7Z84
25 October 2022
RTW Venture Fund Limited
Quarterly Update
RTW Venture Fund Limited (the "Company") is pleased to announce
the Fact Sheet for the quarter ended 30 September 2022 is now
available on the Company's website in the Document Library Section
www.rtwfunds.com/venture-fund.
For Further Information
RTW Investments, LP +44 (0) 77 1741 7711
Woody Stileman, Managing Director
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds
Jérémie Birnbaum
James Bouverat (Sales)
BofA Securities +44 (0) 20 7628 1000
Edward Peel
Kieran Millar
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment
fund focused on identifying transformative assets with high growth
potential across the biopharmaceutical and medical technology
sectors. Driven by a long-term approach to support innovative
businesses, RTW Venture Fund Limited invests in companies
developing next-generation therapies and technologies that can
significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a
leading healthcare-focused entrepreneurial investment firm with
deep scientific expertise and a strong track record of supporting
companies developing life-changing therapies.
Visit the RTW website at www.rtwfunds.com for more
information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDGZMZGVDLGZZM
(END) Dow Jones Newswires
October 25, 2022 02:00 ET (06:00 GMT)
Rtw Biotech Opportunities (LSE:RTW)
過去 株価チャート
から 2 2024 まで 3 2024
Rtw Biotech Opportunities (LSE:RTW)
過去 株価チャート
から 3 2023 まで 3 2024